Andrea Guffanti

568 total citations
20 papers, 409 citations indexed

About

Andrea Guffanti is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Andrea Guffanti has authored 20 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Genetics and 6 papers in Oncology. Recurrent topics in Andrea Guffanti's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Multiple Myeloma Research and Treatments (5 papers). Andrea Guffanti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Multiple Myeloma Research and Treatments (5 papers). Andrea Guffanti collaborates with scholars based in Italy and Switzerland. Andrea Guffanti's co-authors include Luca Baldini, Marina Colombi, I Damilano, Lilla Cro, Maiolo At, Antonino Neri, Anna Teresa Maiolo, Maria Goldaniga, Bruno Mario Cesana and Francesco Bertoni and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Andrea Guffanti

20 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Guffanti Italy 11 214 185 147 105 97 20 409
Warren G. Sanger United States 7 286 1.3× 150 0.8× 221 1.5× 183 1.7× 61 0.6× 9 467
JL Huret France 6 301 1.4× 128 0.7× 154 1.0× 166 1.6× 68 0.7× 100 521
Olivia Minelli Italy 10 197 0.9× 102 0.6× 70 0.5× 121 1.2× 35 0.4× 12 325
K. Adams United Kingdom 6 326 1.5× 135 0.7× 83 0.6× 261 2.5× 57 0.6× 8 520
Junji Hiraga Japan 8 266 1.2× 142 0.8× 79 0.5× 185 1.8× 91 0.9× 17 464
Keiichiro Hattori Japan 12 186 0.9× 96 0.5× 88 0.6× 97 0.9× 83 0.9× 35 346
PA Jr Bunn United States 7 139 0.6× 125 0.7× 69 0.5× 151 1.4× 152 1.6× 11 467
Botond Tímár Hungary 11 176 0.8× 156 0.8× 68 0.5× 114 1.1× 28 0.3× 34 355
Yoshitomo Maesako Japan 10 173 0.8× 117 0.6× 91 0.6× 115 1.1× 27 0.3× 21 370
Fontanet Bijou France 11 234 1.1× 217 1.2× 131 0.9× 233 2.2× 45 0.5× 46 467

Countries citing papers authored by Andrea Guffanti

Since Specialization
Citations

This map shows the geographic impact of Andrea Guffanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Guffanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Guffanti more than expected).

Fields of papers citing papers by Andrea Guffanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Guffanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Guffanti. The network helps show where Andrea Guffanti may publish in the future.

Co-authorship network of co-authors of Andrea Guffanti

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Guffanti. A scholar is included among the top collaborators of Andrea Guffanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Guffanti. Andrea Guffanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cro, Lilla, Andrea Ferrario, Marta Lionetti, et al.. (2010). The clinical and biological features of a series of immunophenotypic variant of B‐CLL. European Journal Of Haematology. 85(2). 120–129. 10 indexed citations
2.
Rossi, Francesca Gaia, Maria Teresa Petrucci, Andrea Guffanti, et al.. (2009). Proposal and Validation of Prognostic Scoring Systems for IgG and IgA Monoclonal Gammopathies of Undetermined Significance. Clinical Cancer Research. 15(13). 4439–4445. 11 indexed citations
3.
Goldaniga, Maria, Andrea Ferrario, Sergio Cortelazzo, et al.. (2008). A multicenter retrospective clinical study of CD5/CD10‐negative chronic B cell leukemias. American Journal of Hematology. 83(5). 349–354. 20 indexed citations
4.
Goldaniga, Maria, Andrea Ferrario, Sergio Cortelazzo, et al.. (2005). CD5 negative chronic B cell leukemias : a polycentric retrospective study. Haematologica. 90. 119–119. 1 indexed citations
6.
Goldaniga, Maria, Andrea Guffanti, Umberto Gianelli, et al.. (2004). Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.. PubMed. 89(11). ECR41–ECR41. 6 indexed citations
7.
Cro, Lilla, Andrea Guffanti, Marina Colombi, et al.. (2003). Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia. 17(1). 125–132. 18 indexed citations
8.
Luminari, Stefano, Maria Goldaniga, Andrea Guffanti, et al.. (2003). Prevalence and prognostic significance of sMUC‐1 levels in plasma cell dyscrasias. British Journal of Haematology. 121(5). 772–774. 5 indexed citations
9.
Colombi, Marina, et al.. (2000). OPP-EBV-CAD Regimen as Salvage Treatment in Advanced Refractory or Resistant Multiple Myeloma. Leukemia & lymphoma. 40(1-2). 87–94. 3 indexed citations
10.
Vener, Claudia, et al.. (2000). Soluble Cytokine Levels Correlate with the Activity and Clinical Stage of Hodgkin's Disease at Diagnosis. Leukemia & lymphoma. 37(3-4). 333–339. 25 indexed citations
11.
Cro, Lilla, Claudia Vener, Andrea Guffanti, et al.. (1999). Intensity of CD20 expression in B-cell lymphoproliferative syndromes. 1999. 198–198. 1 indexed citations
12.
Baldini, Luca, Andrea Guffanti, Vittorio Fossati, et al.. (1998). Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Annals of Oncology. 9(7). 779–781. 61 indexed citations
13.
Baldini, Luca, Andrea Guffanti, Lilla Cro, et al.. (1997). Poor prognosis in non‐villous splenic marginal zone cell lymphoma is associated with p53 mutations. British Journal of Haematology. 99(2). 375–378. 22 indexed citations
14.
Baldini, Luca, Andrea Guffanti, Paolo G. Gobbi, et al.. (1997). A pilot study on the use of the proMACE‐cytaBOM regimen as a first‐line treatment of advanced follicular non‐Hodgkin's lymphoma. Cancer. 79(6). 1234–1240. 10 indexed citations
15.
Parma, Matteo, Giulia Sita, Andrea Guffanti, et al.. (1996). Multilobated B cell lymphoma (Pinkus variant) with isolated muscular localization in a patient with systemic sclerosis: a case report. Annals of Hematology. 73(1). 43–45. 10 indexed citations
16.
Baldini, Luca, et al.. (1996). Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood. 87(3). 912–918. 84 indexed citations
17.
Sita, Giulia, et al.. (1996). Rosai-Dorfman syndrome with extranodal localizations and response to glucocorticoids: a case report.. PubMed. 81(2). 165–7. 8 indexed citations
18.
Baldini, Luca, Andrea Guffanti, D Castagnone, et al.. (1994). Uncommon clinical presentation of a lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis. British Journal of Haematology. 86(3). 657–658. 9 indexed citations
19.
Baldini, Luca, Eduardo Nobile‐Orazio, Andrea Guffanti, et al.. (1994). Peripheral neuropathy in IgM monoclonal gammopathy and wäldenstrom's macroglobulinemia: A frequent complication in elderly males with low MAG‐reactive serum monoclonal component. American Journal of Hematology. 45(1). 25–31. 45 indexed citations
20.
Guffanti, Andrea, et al.. (1983). [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].. PubMed. 62(6). 517–23. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026